Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy.

3008Background: Mutations in DNA polymerase epsilon (POLE) may induce DNA replication errors, increasing neoantigen load and potentially enhancing clinical benefit to immune checkpoint inhibitors (...